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Contact dermatitis caused by diacetylmorphine (heroin) and by mor-
phine have both been described before.1-5 In addition, a case of acute
generalized exanthematous pustulosis (AGEP) as a reaction to mor-
phine has previously been described.6 The present report describes a
patient who was occupationally sensitized to diacetylmorphine, and
developed a skin reaction after receiving morphine following surgery.
CASE REPORT
A 55-year-old woman with a history of occupational contact dermati-
tis caused by diacetylmorphine underwent surgery for a mammary
carcinoma. In the past, she had worked at a municipal treatment cen-
tre for drug addicts until 2000. At that time, she developed allergic
contact dermatitis after contact with diacetylmorphine. Patch testing
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was performed with our departmental extended European baseline
series (TRUE Test panels 1 and 2, supplemented with additional
investigator-loaded allergens), a cosmetic series, and an opiate series
(SmartPractice Europe, Reinbek, Germany). All investigator-loaded
allergens were tested in Van der Bend square chambers (Van der
Bend, Brielle, The Netherlands), and all patch tests were attached to
the back with Fixomull stretch (BSN Medical, Hamburg, Germany) for
2 days. Readings were performed on day (D) 2 and D3.
Patch testing showed positive reactions to morphine hydrochlo-
ride, morphine, diacetylmorphine, and codeine dihydrophosphate
(Table 1). The patient was one of the occupation-related cases
described previously.1,2 Sixteen years later, she underwent a mastec-
tomy. One day after surgery, she developed an erythematous papular
itchy facial rash, which spread over the body on the next day. In addi-
tion, vesicles were seen on the face and neck. No signs of fever, laryn-
gitis or pustules were seen. The patient was treated with clobetasol
ointment for 1 week, with good results.
During mastectomy, the patient had received morphine, cefazolin,
dexamethasone, naproxen, propofol, paracetamol, remifentanil, and
rocuronium. After surgery, she was treated with naproxen, paraceta-
mol, pantoprazole, fraxiparine, and ondansetron. She had never
reacted to paracetamol, ibuprofen, or naproxen. According to Litt’s
drug eruption & reaction database, delayed-type reactions to and
exanthemas caused by the other administered drugs are very rare.7
Hypersensitivity to propofol is also rare, and is almost always reported
in terms of anaphylactoid reactions or anaphylaxis8 We assume that
the patient developed a morphine-induced delayed-type cutaneous
adverse drug reaction following occupational diacetylmorphine
contact dermatitis. An intravenous provocation test to reproduce the
skin reaction was not performed, because of the patient’s severe rash.
DISCUSSION
We assume that the patient described here developed delayed-
type (type IV) systemic allergic dermatitis caused by morphine in
the context of her past occupational contact sensitization to
diacetylmorphine. In 2000, besides stopping occupational expo-
sure, the patient was advised to avoid treatment with morphine,
diacetylmorphine, and codeine, because of the chemical similarities
between these opiates. Nevertheless, she received morphine dur-
ing surgery in 2016.
Contact dermatitis and AGEP caused by diacetylmorphine and
morphine have been reported before.1-6 Furthermore, the chemical
similarities between morphine, diacetylmorphine and codeine are well
known.9 Thyssen and Maibach, along with Schnyder and Pichler,
reviewed the possible pathomechanisms of systemic allergic dermati-
tis.10,11 The exact mechanism remains unclear. However, the pharma-
cological interactions of drugs with immune receptors concept may
explain the predominant skin involvement in T cell-mediated reactions
to systemically applied drugs.11
In conclusion, although definite proof by means of a provocation
test could not be provided, we feel that reporting this case is of
importance to alert those who are occupationally sensitized to opiates
to the risk of skin and systemic reactions in cases of future medication
with these drugs.
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Fentanyl citrate 0.1 pet. − −
Oxycodone 1.0 pet. − −
Piritramide (ampoule,
10 mg/mL aq.)
“as is” − −




“as is” − −
Methadone 1.0 pet. − −
Tramadol 1.0 pet. − −
Caffeine 0.5 pet. − −
Morphine
hydrochloride
1.0 aq. ?+ +
Morphine (10 mg)
powder
“as is” ?+ +
Diacetylmorphine 1.0 pet. ?+ +
Codeine
dihydrophosphate
1.0 eth. ?+ +
Abbreviation: eth., ethanol 70%.
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